Related Experiment Video
Updated: Mar 19, 2026

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
Published on: January 9, 2019
Primary Cardiac Lymphomas: Diagnosis and Management
Alexandra Pons-Riverola1, Maria Clara Llamedo2, Lorcan Ruane2
1Cardio-Oncology Service and Cardio-Oncology Centre of Excellence, Royal Brompton Hospital, London, United Kingdom; Department of Cardiology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; BioHeart Group, Cardiovascular, Respiratory and Systemic Diseases and Cellular Aging Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
Abstract:
Primary cardiac lymphomas (PCLs) are rare and often present a diagnostic challenge because of nonspecific clinical and imaging findings. Delayed diagnosis may lead to rapid clinical deterioration. We report a case series of 6 patients with PCL diagnosed between 2021 and 2025 at 2 tertiary cardio-oncology centers, illustrating the diagnostic pathway, therapeutic strategies, and clinical outcomes. Multimodality imaging was essential for initial evaluation, but histopathologic confirmation was required in all cases. Surgical biopsy proved to be a safe and effective method for tissue diagnosis. Systemic chemotherapy resulted in significant tumor regression or complete resolution in most patients, whereas surgical debulking was reserved for those with hemodynamic compromise. This case series highlights key diagnostic and management considerations that may assist clinicians facing suspected PCL.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy VI: Nursing Management